ZHIFEI-BIOL (300122.SZ) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

ZHIFEI-BIOL released FY2025 Q3 earnings on October 29 During-Market (BJT), actual revenue CNY 2.708 B (forecast CNY 3.212 B), actual EPS CNY -0.2546 (forecast CNY 0.0382)

01:00

ZHIFEI-BIOL released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 7.627 B, actual EPS CNY -0.504

01:00

Oct22

ZHIFEI-BIOL to Release FY2025 Q3 Earnings on October 30 During-Market (BJT), Forecast Revenue CNY 3.212 B, EPS CNY 0.0382

01:54

Aug18

ZHIFEI-BIOL released FY2025 Semi-Annual earnings on August 18 After-Market (BJT), actual revenue CNY 4.919 B, actual EPS CNY -0.2494

01:00

ZHIFEI-BIOL released FY2025 Q2 earnings on August 18 After-Market (BJT), actual revenue CNY 2.545 B (forecast CNY 3.677 B), actual EPS CNY -0.1219 (forecast CNY 0.0856)

01:00

Aug13

Changfei Biologics Subsidiary Completes First National Inoculation of Quadrivalent Influenza Vaccine

06:53

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 2.708 B, Net Income -609.32 M, EPS -0.2546

Aug19

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug18

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 2.545 B, Net Income -291.95 M, EPS -0.1219

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More